112 related articles for article (PubMed ID: 16522180)
1. Expression and purification of soluble non-fusion vasostatin in Escherichia coli.
Wu X; Li X; Su Z; Zheng Q; Xu H; Wu S; Feng Y; Zhao W
Protein Pept Lett; 2005 Oct; 12(7):659-61. PubMed ID: 16522180
[TBL] [Abstract][Full Text] [Related]
2. Expression, purification and biological characterization of human vasostatin120-180 in Pichia pastoris.
Lin Y; Yang X; Lu M; Zhuang H; Hua ZC
Protein Expr Purif; 2013 Dec; 92(2):141-7. PubMed ID: 24096091
[TBL] [Abstract][Full Text] [Related]
3. Expression, purification of human vasostatin120-180 in Escherichia coli, and its anti-angiogenic characterization.
Sun QM; Cao L; Fang L; Chen C; Dai J; Chen LL; Hua ZC
Protein Expr Purif; 2005 Feb; 39(2):288-95. PubMed ID: 15642481
[TBL] [Abstract][Full Text] [Related]
4. Novel fusion protein derived from vasostatin 30 and vasoinhibin II-14.1 potently inhibits coronary endothelial cell proliferation.
Vazquez Rodriguez G; Gonzalez C; De Leon Rodriguez A
Mol Biotechnol; 2013 Jul; 54(3):920-9. PubMed ID: 23315240
[TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of the active fragment of human vasostatin Vs30 in Pichia pastoris SMD1168H.
Calderon-Salais S; Velazquez-Bernardino P; Balderas-Hernandez VE; Barba de la Rosa AP; De Leon-Rodriguez A
Protein Expr Purif; 2018 Apr; 144():40-45. PubMed ID: 29221829
[TBL] [Abstract][Full Text] [Related]
6. An improved strategy for high-level production of human vasostatin120-180.
Sun QM; Chen LL; Cao L; Fang L; Chen C; Hua ZC
Biotechnol Prog; 2005; 21(4):1048-52. PubMed ID: 16080682
[TBL] [Abstract][Full Text] [Related]
7. Plasmid-encoding vasostatin inhibited the growth and metastasis of human hepatocellular carcinoma cells.
Peng XC; Wang M; Chen XX; Liu J; Xiao GH; Liao HL
Mol Cell Biochem; 2014 Oct; 395(1-2):265-72. PubMed ID: 24997628
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of vasostatin, a calreticulin fragment, into neuroendocrine tumor cells results in enhanced malignant behavior.
Liu M; Imam H; Oberg K; Zhou Y
Neuroendocrinology; 2005; 82(1):1-10. PubMed ID: 16293970
[TBL] [Abstract][Full Text] [Related]
9. [Soluble high-expression, purification and bioassay of IGFBP-3].
Wu C; Yao GY; Zou MJ; Chen GY; Wang M; Wang JX; Xu DG
Sheng Wu Gong Cheng Xue Bao; 2007 May; 23(3):398-402. PubMed ID: 17577982
[TBL] [Abstract][Full Text] [Related]
10. Expression of soluble, biologically active recombinant human tumstatin in Escherichia coli.
Luo YQ; Wang LH; Yi Q; Jiao BH
Clin Exp Med; 2008 Mar; 8(1):37-42. PubMed ID: 18385939
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of a recombinant fragment of human fibronectin containing the Cell I-Hep II-IIICS71 domain in Escherichia coli as a soluble protein.
Li M; Feng Z; Zhang G; Li D
Biotechnol Lett; 2006 Jul; 28(14):1141-6. PubMed ID: 16794767
[TBL] [Abstract][Full Text] [Related]
12. Efficient refolding of the bifunctional therapeutic fusion protein VAS-TRAIL by a triple agent solution.
Fan J; Wang Z; Huang L; Shen Y
Protein Expr Purif; 2016 Sep; 125():68-73. PubMed ID: 26358405
[TBL] [Abstract][Full Text] [Related]
13. Examination of alternate codon bias solutions for expression and purification of recombinant mechano-growth factor in Escherichia coli.
Feng J; Wan R; Yi Q; He L; Yang L; Tang L
Biotechnol Appl Biochem; 2015; 62(5):690-8. PubMed ID: 25345350
[TBL] [Abstract][Full Text] [Related]
14. Soluble recombinant endostatin purified from Escherichia coli: antiangiogenic activity and antitumor effect.
Huang X; Wong MK; Zhao Q; Zhu Z; Wang KZ; Huang N; Ye C; Gorelik E; Li M
Cancer Res; 2001 Jan; 61(2):478-81. PubMed ID: 11212235
[TBL] [Abstract][Full Text] [Related]
15. Aristolochene synthase: purification, molecular cloning, high-level expression in Escherichia coli, and characterization of the Aspergillus terreus cyclase.
Cane DE; Kang I
Arch Biochem Biophys; 2000 Apr; 376(2):354-64. PubMed ID: 10775423
[TBL] [Abstract][Full Text] [Related]
16. High-level Expression of Tetanus Toxin Fragment C in Escherichia coli.
Aghaiypour K; Teymourpour R
Arch Razi Inst; 2018 Dec; 73(1):27-38. PubMed ID: 30256036
[TBL] [Abstract][Full Text] [Related]
17. Strategy for linker selection to enhance refolding and bioactivity of VAS-TRAIL fusion protein based on inclusion body conformation and activity.
Fan J; Huang L; Sun J; Qiu Y; Zhou J; Shen Y
J Biotechnol; 2015 Sep; 209():16-22. PubMed ID: 26072465
[TBL] [Abstract][Full Text] [Related]
18. Application of an Autoinduction Strategy to Optimize the Heterologous Production of an Antitumor Bispecific Fusion Protein Based on the TRAIL Receptor-Selective Mutant Variant in Escherichia coli.
Isakova A; Artykov A; Vorontsova Y; Dolgikh D; Kirpichnikov M; Gasparian M; Yagolovich A
Mol Biotechnol; 2023 Apr; 65(4):581-589. PubMed ID: 36094644
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice.
Li L; Yuan YZ; Lu J; Xia L; Zhu Y; Zhang YP; Qiao MM
Gut; 2006 Feb; 55(2):259-65. PubMed ID: 16287901
[TBL] [Abstract][Full Text] [Related]
20. [Bioluminescent imaging monitoring of a anti-angiogenesis therapeutic gene vasostatin in tumor cell PC3].
Hu JM; Qiu FC; Yin B; Gong YH; Yuan JG; Qiang BQ; Wang SZ; Peng XZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):312-7. PubMed ID: 17633454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
